London
Roots Analysis has announced the addition of “Large Volume WearableInjectors Market (5th Edition), 2020-2030: Focus on Bolus, Basal and ContinuousDelivery Devices” reportto its list of offerings.
Thewide-spread prevalence of chronic diseases has compelled drug developers toinnovate and design better, moreadvanced healthcare solutions. Large volume wearable injectors were developedto specifically address certain challenges associated with the administrationof high volume formulations, viscous drugsolutions and cater to frequent dosing requirements of patients sufferingfrom chronic health conditions.
To order this 500+ page report, whichfeatures 175+ figures and 200+ tables, please visit –
Key MarketInsights
More than25 large volume wearable injectors are presently available / under development forthe administration of drugs, excluding insulin
Over 45% ofthe abovementioned devices are capable of delivering bolus doses, followed bydevices designed for continuous dosing at pre-programmed rates (15 %). Thesedevices are powered by a diverse variety of actuation mechanisms, includingrotary pumps, cells / expanded batteries, springs, osmotic pressure andliquefied gas. It is worth noting that over 15+ known drug-device combinationsare commercialized / under development.
Forinsulin delivery alone, there are 30+ large volume wearable injectors available/ under development
It isworth highlighting that nearly 40% of the abovementioned devices presently useadvanced algorithms in order to automate the delivery of insulin, based onintegrated continuous blood glucose monitoring systems. Of these, majority(23%) use the hybrid closed loop system. Over 80% of such devices have specialconnectivity features that enable better dosage monitoring.
More than200 biologics / small molecule drugs were identified as likely products to bedeveloped in combination with large volume wearable injectors
The reportprovides insights on over 800 marketed drugs / therapies and pipelinecandidates, assessing the likelihood of whether they can be developed incombination with large volume wearable injectors. The analysis takes intoconsideration current phase of development of the drug, its dosage, doseconcentration, route of administration, type of dose and information on drugsales (for marketed drugs).
Nearly90 partnerships have been signed by developers of large volume wearableinjectors between 2015 and 2020 (till March)
It isworth noting that more than 55% deals were established post 2017, indicating anincrease in the partnership activity within this domain. Majority ofpartnership deals were product / technology integration agreements (29%),followed by deals focused on product development and commercialization (23%), mergersand acquisitions (12%), and product distribution (12%).
NorthAmerica and Europe are anticipated to capture over 60% of the market share, interms of revenues generated from sales of non-insulin drug delivery devices, in2030
By 2030,46% of revenues are expected to be generated from the sales of large volumewearable injectors intended for the treatment of neurological disorders,followed by products for oncological disorders (27%), cardiovascular disorders(25%) and infectious diseases (2%).
Thelarge volume wearable injectors market for insulin is anticipated to be worth overUSD 2.7 billion by 2030
NorthAmerica presently dominates the global insulin market, consequently the regionis expected to capture the majority share (50%) in terms of revenues fromwearable injector sales. It is worth highlighting that the market in Asia-pacific is anticipated to growat a relatively faster pace.
To request a sample copy / brochure of thisreport, please visit this - https://www.rootsanalysis.com/reports/238/request-sample.html
KeyQuestions Answered
§ Who are the leading developers of large volume wearable devices?
§ What are the prevalent trends within the large volume wearableinjectors market?
§ Which drug candidates are suited for delivery via large volumewearable injectors?
§ Who are the key contract service providers in this domain?
§ What are the various regulatory guidelines issued for medicaldevices across different regions?
§ How is the current and future market opportunity likely to bedistributed across key market segments?
The financial opportunity withinthe large volume wearable injectors market (for delivery of non-insulin andinsulin drugs) has been analyzed across the following segments:
§ Typeof Device
- Patch Pump / Injectors
- Infusion Pump / Injectors
§ ProductUsability
- Disposable
- Re-usable
§ TherapeuticArea (for non-insulin drugs)
- Neurological Disorders
- Cardiovascular Disorders
- Oncological Disorders
- Infectious Disorders
§ Key geographical regions
- North America
- Europe
- Asia Pacific and Rest of the World
The research includes detailedprofiles of key players (listed below); each profile features anoverview of the company, its financial information (if available), a description of the product(s)offered, details of recent developments related to large volume wearableinjection devices and an informed future outlook.
§ Becton Dickinson
§ Bespak (subsidiary of Consort Medical)
§ CeQur
§ Debiotech
§ Eli Lilly
§ Enable Injections
§ Insulet
§ Medtronic
§ PharmaSens
§ Roche
§ SOOIL Development
§ Sonceboz
§ Sensile Medical (acquired by Gerresheimer)
§ SteadyMed Therapeutics (acquired by United Therapeutics)
§ Tandem Diabetes Care
§ Weibel CDS (acquired by SHL Medical)
§ West Pharmaceutical Services
For additional details, pleasevisit
https://www.rootsanalysis.com/reports/view_document/large-volume-wearable-injectors-market-4th-edition-2018-2030/238.html[Jasparam1]
You may also be interested in thefollowing titles:
2. Global AutoinjectorsMarket (3rd Edition), 2020-2030
3. Prefilled SyringesMarket (5th Edition), 2020-2030
About Roots Analysis
Roots Analysis is one of the fastest growingmarket research companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
Contact Information
Gaurav Chaudhary
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis
[Jasparam1]Arunto assist.
The link name shows large volume wearable injectors,even on the website.
